China GMP and ISO 13485: A Side-by-Side Comparison
China GMP and ISO 13485: A Side-by-Side Comparison
My Profile
Member Center
Policy
Top Priorities
On behalf of our members, AdvaMed® works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
Your Featured Resources
Clinical Evidence for IVD Medical Devices
AdvaMed’s feedback on the CEIVD draft outlines targeted recommendations to improve clarity in clinical evidence expectations for IVD devices, including more precise terminology, alignment with global frameworks, and clearer distinctions…
AdvaMed’s Comments on EPA Sterilization Emissions Standards
AdvaMed outlines recommendations to ensure EPA’s proposed ethylene oxide (EtO) emissions standards protect public health while maintaining access to life-saving medtech.
AdvaMed® Advancements: Q1 2026 Report
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
AdvaMed® Comment Letter to FDA: Exemptions from Premarket Notification Requirements for Class II Devices
AdvaMed’s® comments on FDA’s 510(k) exemption framework for Class II devices and its impact on innovation and patient access.
2025 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2025 on behalf of our member companies and the patients they serve.
Additional Resources
China GMP and ISO 13485: A Side-by-Side Comparison
China GMP and ISO 13485: A Side-by-Side Comparison
Clinical Evidence for IVD Medical Devices
AdvaMed’s feedback on the CEIVD draft outlines targeted recommendations to improve clarity in clinical evidence expectations for IVD devices, including more precise terminology, alignment with global frameworks, and clearer distinctions…
AdvaMed’s Comments on EPA Sterilization Emissions Standards
AdvaMed outlines recommendations to ensure EPA’s proposed ethylene oxide (EtO) emissions standards protect public health while maintaining access to life-saving medtech.
AdvaMed® Advancements: Q1 2026 Report
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
Discover More Resources
AdvaMed® members have access to our full library of industry resources.
You are not logged in to the AdvaMed Hub.
Medtech Moves Us: The Theme Behind #MTC26
This October 18–21, innovators, executives, investors, policymakers, clinicians, entrepreneurs, and industry partners will gather in Boston for our industry’s premier event. I hope your organization is making plans to join…
AdvaMed Statement on the Klomp Nomination
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the…
JAMA Surgery Publishes Landmark BrIMA Study Demonstrating Significant Improvement in Intraoperative Margin Assessment with Specimen PET-CT
GHENT, BELGIUM — XEOS, a medical technology company advancing intraoperative molecular imaging, today announced the publication of the BrIMA (Breast cancer Intraoperative Margin Assessment) study in JAMA Surgery, world’s leading…
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of…
AdvaMed Earns WTOP News Regional Top Workplaces 2026 Award, Culture Excellence Awards
Washington, D.C.—AdvaMed, the largest trade association representing medtech innovators, announced today it is a WTOP News Top Workplaces 2026 award winner in the Washington, D.C., region and received five Culture…
Sonex Health Announces Data from Largest-ever U.S. Study Proving UltraGuideCTR™ Delivers Compelling Results for Carpal Tunnel Patients
EAGAN, Minn. – June 9, 2026 – Sonex Health, Inc. (Sonex Health) and The Institute of Advanced Ultrasound Guided Procedures today announced publication of six-month data demonstrating the safety and efficacy…
AdvaMed-Supported State Legislative Wins Advance Patient Access Across the U.S.
Millions of patients’ lives are improved every day because of advancements in medical technology. But too often, gaps in coverage and access prevent patients from benefiting from the safe, effective,…
UltraSight™ Study Shows Novices Achieve Diagnostic-Quality Cardiac Ultrasound After One Day of AI-Guided Training
BOSTON, MA, UNITED STATES, May 26, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced publication of a multicenter peer-reviewed study in European Heart Journal – Digital…
Medtech Compliance Is More Complex so We Built a Program to Match
The AdvaMed Medtech Compliance Workshop is a forum designed specifically for medtech compliance leaders and legal and other professionals with health care compliance responsibilities.
UltraSight™ Appoints Rick Geoffrion as Chairman of the Board
BOSTON, MA, UNITED STATES, May 19, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging, today announced the appointment of Rick Geoffrion as Chairman of the Board. Mr. Geoffrion…
Membership Newsletter
We are pleased to provide AdvaMed® members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.